G13.2
Billable

Systemic atrophy primarily affecting the central nervous system in myxedema

Billable / Specific Code

What is Systemic atrophy primarily affecting the central nervous system in myxedema?

ICD-10-CM G13.2 is the diagnosis code for Systemic atrophy primarily affecting the central nervous system in myxedema. This code falls under the section "Systemic atrophies primarily affecting the central nervous system" within Chapter 6 — Diseases of the nervous system (G00-G99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.

Coding Guidelines for G13.2

Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.

ICD-10-CM Code Hierarchy

Understanding where G13.2 sits in the ICD-10-CM classification helps ensure proper coding:

Related Codes

Frequently Asked Questions

Is G13.2 a billable ICD-10-CM code?

Yes, G13.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What does G13.2 mean?

G13.2 is the ICD-10-CM diagnosis code for "Systemic atrophy primarily affecting the central nervous system in myxedema". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.

What is the parent code of G13.2?

The parent code of G13.2 is G13 ("Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere"). G13.2 provides a more specific classification within this category.

What section is G13.2 in?

G13.2 is located in Section G10-G14 — "Systemic atrophies primarily affecting the central nervous system" within Chapter 6 of the ICD-10-CM Tabular List.

When should I use G13.2?

Use G13.2 when the patients documented diagnosis matches "Systemic atrophy primarily affecting the central nervous system in myxedema" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.

People Also Ask

What is the ICD-10 code for Systemic atrophy primarily affecting the central nervous system in myxedema?

The ICD-10-CM code for Systemic atrophy primarily affecting the central nervous system in myxedema is G13.2.

Can G13.2 be used for primary diagnosis?

Yes, G13.2 can be used as a primary diagnosis code since it is billable and specific.

What chapter is G13.2 in?

G13.2 is in Chapter 6 of the ICD-10-CM Tabular List.

Is G13.2 valid for 2026?

Yes, G13.2 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.

See Also

← PreviousG13.1Other systemic atrophy primarily affecting central nervous system in neoplastic diseaseNext →G13.8Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
Code Details
G13.2
Systemic atrophy primarily affecting the central nervous system in myxedema
Billable / Specific Code
6 — Diseases of the nervous system (G00-G99)
G10-G14 — Systemic atrophies primarily affecting the central nervous system
2026 ICD-10-CM